KNW: Know Labs EV/EBITDA Multiple
Know Labs, Inc. (KNW) is developing as a defensive asset, as demand for medtech remains independent of macroeconomic fluctuations. The company is creating non-invasive glucose monitoring systems, planning to monetize AI algorithms through licensing for electronics manufacturers. The market capitalization trend at the level reflects the business value dynamics. Ultimately, Know Labs, Inc. (KNW) is establishing a unique health monitoring ecosystem by integrating radio-frequency sensors into wearable gadgets.
Summary analytical data breakdowns for knowlabs.co (KNW)
- stock price and consensus target price:
- market capitalization information:
- issuer book value statistics:
- company liabilities and liquidity data:
- financial results and valuation multiples details:
KNW - Net Income|Projected Future Earnings Know Labs, Inc.|KNW - P/E Multiple|Future Price to Earnings Know Labs, Inc.|KNW - Price/Earnings to Growth Ratio|Enterprise Value to EBITDA Ratio Know Labs Corporation|KNW - Income before deduction of interest, taxes and amortization|Net earnings per share (EPS TTM) Know Labs|KNW - Net earnings per one share for the last twelve months|Year-over-year earnings per share growth for the last twelve months knowlabs.co|KNW - Net earnings per share change in current year|Expected earnings per share growth for next year Know Labs, Inc.
Initial company analysis:Know Labs Corp KNW
EV/EBITDA determines the enterprise value, including net debt, relative to its operating profit before taxes, depreciation, and amortization. By analyzing the EV/EBITDA multiple, an investor assesses the payback period for capital-intensive assets while accounting for the debt load. For Know Labs, Inc. (KNW), this indicator reflects the speculative value of future non-invasive glucose monitoring technologies while the market awaits official regulatory confirmation of the product's efficacy.
Competitor analysis for Know Labs, Inc.
Dexcom Corp - Enterprise Value to EBITDA Ratio|Enterprise Value to Operating Income Before Depreciation Ratio PEN (Penumbra Medical)|Novanta Inc. - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio haemonetics.com HAE|INSP: EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio PROCEPT BioRobotics Corp|Enterprise Value to EBITDA Ratio CNMD|PLSE: Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization InMode Ltd. (INMD)|Enterprise Value to EBITDA Ratio picardmedical.com PMI|EV/EBITDA Multiple SRDX (Surmodics)|Senseonics Corp (SENS) - Company Value to EBITDA|NeuroPace Corp - EV/EBITDA Multiple|TCMD (Tactile Systems Technology) - Enterprise Value to Operating Income Before Depreciation|SNWV: EV/EBITDA Multiple|OM - Total Company Value to Operating Income Before Depreciation Ratio|ELMD (SmartVest) - EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio LENSAR Inc. (LNSR)|EV/EBITDA Multiple RCEL|EV/EBITDA Multiple profoundmedical.com (PROF)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Baird Medical BDMD|EDAP TMS SA - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|APYX: Enterprise Value to EBITDA Ratio|Business Value to Operating Income Before Depreciation ICCM (IceCure Medical Ltd)|LUNG: EV/EBITDA Multiple|Company Value to EBITDA TELA Bio (TELA)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization CytoSorbents Corp|SRTS - Enterprise Value to EBITDA Multiple|Enterprise Value to EBITDA Ratio ZYXI (Zynex)|EV/EBITDA Multiple electrocore.com (ECOR)|EV/EBITDA Multiple RBOT (Vicarious Surgical)|Total Company Value to Operating Income Before Depreciation Ratio Inspira Technologies Oxy B.H.N. Ltd. (IINN)|ICU - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to Operating Income Before Depreciation Ratio IRIX|ibs.inc (INBS) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio Beyond Air|PFSA (Profusa, Inc.) - EV/EBITDA Multiple|Company Value to EBITDA STRATA Skin SSKN|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization GlucoTrack, Inc. (GCTK)|nanovibronix.com - Enterprise Value to Operating Income Before Depreciation|Venus Concept - Enterprise Value to EBITDA Ratio|Enterprise Value to Operating Income Before Depreciation Ratio NUWE (Nuwellis Inc)|AEMD - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|ASXC - EV/EBITDA Multiple|Avinger, Inc. (AVGR) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to Operating Income Before Depreciation BSGM|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Cutera|Company Value to EBITDA Inari Medical Inc NARI|Enterprise Value to EBITDA Ratio NVRO (Nevro Corporation)|Enterprise Value to EBITDA Ratio reshapelifesciences.com RSLS|Silk Road Medical, Inc - Enterprise Value to EBITDA Ratio
